CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kips Bay Medical, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kips Bay Medical, Inc.
3405 Annapolis Ln N
Phone: (763) 235-3540p:763 235-3540 MINNEAPOLIS, MN  55447-5342  United States Ticker: KIPSKIPS

This company ceased filing statements with the SEC on 9/22/2015.
This company is no longer actively traded on any major stock exchange.

Business Summary
Kips Bay Medical, Inc. is a medical device company focused on developing, manufacturing and commercializing its external saphenous vein support technology (eSVS MESH) for use in coronary artery bypass grafting (CABG) surgery. The Company’s eSVS MESH is a nitinol mesh sleeve that, when placed over a saphenous vein graft during CABG surgery, is designed to improve the structural characteristics and performance of the vein graft. The eSVS MESH is a kink-resistant extravascular tubular prosthesis made of knitted nickel/titanium, or nitinol, wire mesh. The eSVS Mesh is designed to be fitted like a sleeve on the outside of saphenous vein grafts to strengthen SVGs used in coronary artery bypass graft surgery. It is designed to provide the vein graft with physiological attributes similar to those of an artery by strengthening the vessel wall, reducing the lumen diameter and improving blood flow characteristics.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/27/201512/31/2014YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Vice President - Finance ScottKellen 49 9/22/2015 2/8/2010

General Information
Number of Employees: 14 (As of 12/31/2013)
Outstanding Shares: 33,014,079 (As of 8/4/2015)
Shareholders: 64
Stock Exchange: OTC
Federal Tax Id: 208947689
Fax Number: (763) 235-3545


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023